Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combined Biosensor Strategy Detects Infectious Pathogens

By LabMedica International staff writers
Posted on 14 Jun 2013
A method has been developed that combines deoxyribozyme technology with gold nanoparticles to give a simple point-of-care (POC) diagnostic technique that can be used in remote settings.

The technique merges the colorimetric coupling of surface plasmons of gold nanoparticles (GNPs) with deoxyribozyme (DNAzyme) signal amplification technology to create a fast and simple detection method for genetic targets with a simple colorimetric readout.

Chemical engineers at the University of Toronto (ON, Canada) implemented a genetic sensing assay in a simple two-step system. In the amplification step, a buffered mix of multicomponent nucleic acid enzymes (MNAzymes) and linkers is added to the sample solution and incubated at 50 °C for one hour. If target sequences are present, they bind and activate the MNAzymes. Each active MNAzyme in turn catalyzes cleavage of multiple linkers, which effectively translates into signal amplification.

Any linkers that remained uncleaved caused aggregation of the corresponding GNP pairs, turning the solution purple. In contrast, linkers cleaved by target-activated MNAzymes were not able to cross-link the associated GNP pairs, and solution remained red. In one test for the pathogen Neisseria gonorrhoeae, the mixtures in the specific detection tubes remained red. Following this method, the scientist successfully detected five targets simultaneously. In addition, the assay with lyophilized components was used to correctly identify gonorrhea, malaria, and hepatitis B virus sequences in a sample mixture that contained three out of the five targets. All RNA-containing Linker DNA strands were obtained from Integrated DNA Technologies (Coralville, IA, USA) in purified lyophilized form and all other DNA sequences were from BioBasic (Markham, ON, Canada).

The authors concluded that the assay can detect multiple genetic sequences in parallel and that it could be easily applied to other nucleic acid targets. The color-based readout does not require any complex equipment and uses stable and cost-effective reagents, making this approach particularly suitable for POC testing. Warren C. W. Chan, PhD, a professor in nanobiotechnology and the senior author, said, “There's been a lot of emphasis in developing simple diagnostics. The question is how do you make it simple enough, portable enough? Gold is the best medium, because it's easy to see. It emits a very intense color." The article was published on March 11, 2013, in the journal Angewandte Chemie.

Related Links:

University of Toronto

Integrated DNA Technologies

BioBasic





Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.